Skip to content

Tortle Midliner and Intraventricular Hemorrhage

An Evaluation of Early Use of the Tortle Midliner and Intraventricular Hemorrhage (IVH) Outcomes in Premature Babies: A Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03543046
Acronym
IVH
Enrollment
27
Registered
2018-06-01
Start date
2018-08-24
Completion date
2020-01-09
Last updated
2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraventricular Hemorrhage of Prematurity

Brief summary

The purpose of the study is to determine if early application of the Tortle Midliner for preterm infants, ≤ 3 hours following birth and with subsequent continuous use through 72 hrs. of life to ensure maintenance of optimal midline positioning (Tortle group), will impact the IVH outcome as determined by a reduction in the rate and/or severity of IVH when compared to infants receiving the standard regimen of care (Control group).

Detailed description

Intraventricular hemorrhage (IVH) is defined as bleeding into the ventricles of the premature infant brain-the highest risk for the lowest gestational ages. IVH almost always occurs between birth and the first 72 hours of life. The four grades of IVH are based on the degree of bleeding; the greater the severity of the bleed, the more likely to have a poor outcome. Complications can include hydrocephalus, mental retardation, cerebral palsy and seizures. Neurologic sequelae can lead to death. Even for low grade bleeds the studies show the negative effects on cognitive scores and an increased incidence of learning disabilities. In addition, these same children often suffer from attention deficit disorder and other behavioral dysfunctions, which require intervention in order for the child to successfully integrate into school and society. Since increased risk of IVH can be associated with changes of intracranial pressure, many medical protocols have established IVH bundles which are designed to help reduce fluctuations in intracranial pressure while managing the micro-preemie infant during the first few days of life. The correlation between IVH and head positioning of the extremely low birth weight infants has made its way into research literature suggesting that venous obstruction can result from increased external pressure on the venous system when the micro-preemie infant has their head positioned to the side rather than maintaining a neutral position. Therefore, the investigators are aiming to conduct a prospective randomized controlled trial in order to answer the research question: Does early use of the Tortle Midliner reduce the incidence and/or level of severity of intraventricular hemorrhage if used in infants born at ≤ 30 6/7 weeks and neutral position is maintained for the first 72 hours of life? The investigators hypothesize that the use of early consistent neutral positioning compared to the standard care (nested positioning) practiced in the Neonatal Intensive Care Unit (NICU) will reduce the risk of intraventricular hemorrhage in preterm infants born at ≤ 30 6/7 weeks and have a positive effect on the incidence and/or level of severity of intraventricular hemorrhage in this population.

Interventions

The Tortle Midliner will be applied in the treatment group within the first 3 hours of life and maintained until 72 hours of life.

Sponsors

Orlando Health, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 31 Weeks
Healthy volunteers
No

Inclusion criteria

1. Gestational age less than or equal to 30 6/7 weeks at birth 2. Less than 3 hours from birth 3. Informed consent obtained from parent or legal guardian prior to reaching time point for randomization

Exclusion criteria

1. Presence of genetic/chromosomal abnormality, congenital hydrocephalus, congenital neuromuscular disorder, or other diagnosis determined to impact survival or generalizability of results 2. Unable to participate for any reason based on the decision of the principal investigator. 3. Infants born outside Winnie Palmer Hospital for Women and Babies

Design outcomes

Primary

MeasureTime frameDescription
Incidence and Severity of Intraventricular Hemorrhage in Preterm InfantsIVH incidence and/or severity within the first week of lifeData analysis will include descriptive statistics with means and proportions. Comparative statistics will be used to compare IVH outcomes in the two groups. IVH outcome will be determined by a reduction in the incidence and/or severity of IVH. Any additional information on data points may be described in tables and/or graphs.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited in the NICU that met inclusion criteria

Pre-assignment details

27 subjects were randomized. 13 enrolled into the control arm and 14 in the treatment arm. 5 subjects were withdrawn after randomization ( 2 in the control arm and 3 in the treatment arm). 22 Completed study

Participants by arm

ArmCount
Tortle Midliner
The use of the Tortle Midliner will be in addition to the NICU department process guidelines for positioning relevant to the gestational age of the subject. The Tortle Midliner will be applied no later than 3 hours following birth under the supervision of a study investigator. The size/fit and application of the device will be according to the manufacturer's guidelines. The neutral midline head position, supine or slightly side-lying, with a bed elevation between 15° and 30° will be maintained during the first 72 hours of life. Tortle Midliner: The Tortle Midliner will be applied in the treatment group within the first 3 hours of life and maintained until 72 hours of life.
14
Control Group
All clinical care for the control group will be within NICU department process guidelines relevant to the gestational age of the subject and as ordered by physician and/or ARNP providers. The neutral midline head position with the aid of nesting and/or rolls with a bed elevation between 15° and 30° will be maintained throughout position changes during the first 72 hours of life, which is standard practice. Caregivers will document the NICU integrated flowsheet and the Sunrise electronic record with interventions regarding positioning, handling, skin assessment etc. per standard practice requirements.
13
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event11
Overall StudyPhysician Decision11
Overall StudyProtocol Violation10

Baseline characteristics

CharacteristicTortle MidlinerControl GroupTotal
Age, Categorical
<=18 years
14 Participants13 Participants27 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
5 Participants5 Participants10 Participants
Race (NIH/OMB)
More than one race
5 Participants2 Participants7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
3 Participants6 Participants9 Participants
Sex: Female, Male
Female
6 Participants4 Participants10 Participants
Sex: Female, Male
Male
8 Participants9 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 141 / 13
other
Total, other adverse events
0 / 140 / 13
serious
Total, serious adverse events
1 / 142 / 13

Outcome results

Primary

Incidence and Severity of Intraventricular Hemorrhage in Preterm Infants

Data analysis will include descriptive statistics with means and proportions. Comparative statistics will be used to compare IVH outcomes in the two groups. IVH outcome will be determined by a reduction in the incidence and/or severity of IVH. Any additional information on data points may be described in tables and/or graphs.

Time frame: IVH incidence and/or severity within the first week of life

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Tortle MidlinerIncidence and Severity of Intraventricular Hemorrhage in Preterm InfantsIncidence of IVH3 Participants
Tortle MidlinerIncidence and Severity of Intraventricular Hemorrhage in Preterm InfantsIncidence of no IVH8 Participants
Control GroupIncidence and Severity of Intraventricular Hemorrhage in Preterm InfantsIncidence of IVH3 Participants
Control GroupIncidence and Severity of Intraventricular Hemorrhage in Preterm InfantsIncidence of no IVH8 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026